Innate Pharma SA
For the period ended Aug 19, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Aug 19, 2026 · Filed Aug 19, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · 7.1 Amendment; Termination
7.1 Amendment; Termination
Neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the Company and the Investor, except that this Agreement shall be terminated if the Placement Agreement is terminated pursuant to its terms or if the Closing has not occurred by 5:00 p.m. Paris time on August 31, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.